Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits-Reference-Cited by-同舟云学术

Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits

Published:2006-05 Issue:5 Volume:17 Page:813-817
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Yang C.H.,Gonzalez-Angulo A.M.,Reuben J.M.,Booser D.J.,Pusztai L.,Krishnamurthy S.,Esseltine D.,Stec J.,Broglio K.R.,Islam R.,Hortobagyi G.N.,Cristofanilli M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/5/813/404835/mdj131.pdf

Reference24 articles.

1. Cancer statistics, 2005;Jemal;CA Cancer J Clin,2005

2. Advances in screening, diagnosis, and treatment of breast cancer;Mincey;Mayo Clin Proc,2004

3. Chemotherapy of breast cancer a historical perspective;Hortobagyi;Semin Oncol,1997

4. Treatment of metastatic disease;Honig,1996

5. Treatment of metastatic malignant melanoma;Falkson;Anticancer Drugs,1995

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer;British Journal of Cancer;2024-09-09

2. Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer;PLOS ONE;2024-02-27

3. Single-cell morphological and transcriptome analysis unveil inhibitors of polyploid giant breast cancer cells in vitro;Communications Biology;2023-12-21

4. Sniping Cancer Stem Cells with Nanomaterials;ACS Nano;2023-11-27

5. Computational Techniques for Predicting Response to Therapy for Cancer;2023 7th International Conference On Computing, Communication, Control And Automation (ICCUBEA);2023-08-18